RxDoctor Payments Data

Colby Frost

Foot & Ankle Surgery · South Ogden, UTNPI 1619284627

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Arthrex at 57.9% of the total. Reporting peaked in 2020 at $5,105 and has fallen 69.7% since, to $1,547 in 2025.

$8,629in general payments, 2019–2025

Across 31 payments — averaging $278.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Treace Medical Concepts, Inc.$2K
  • Paragon 28, Inc.$831
  • Active Medical, LLC$180
  • Boston Scientific$69
  • Stryker$44
  • plus $99 from 3 others

What the payments were for

  • Speaking & faculty fees$5,00058%
  • Travel & lodging$2,70031%
  • Food & beverage$85310%
  • Education$751%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,629 in reported general payments places this provider in the 75th percentile of 104 foot & ankle surgery providers in Utah.

See all foot & ankle surgery providers in Utah

Medicare billing

Part B allowed, 2024
$62,087
Medicare patients
131
Services billed
580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort12$1,292
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$95
Ibuprofen14$87

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in South Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →